E. Krustev Et Al. , "M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort," ARTHRITIS & RHEUMATOLOGY , pp.626-630, 2022
Krustev, E. Et Al. 2022. M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort. ARTHRITIS & RHEUMATOLOGY , 626-630.
Krustev, E., Hanly, J., Chin, R., Buhler, K., Cardwell, F. S., Urowitz, M., ... Gordon, C.(2022). M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort. ARTHRITIS & RHEUMATOLOGY , 626-630.
Krustev, Eugene Et Al. "M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort," ARTHRITIS & RHEUMATOLOGY , 626-630, 2022
Krustev, Eugene Et Al. "M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort." ARTHRITIS & RHEUMATOLOGY , pp.626-630, 2022
Krustev, E. Et Al. (2022) . "M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort." ARTHRITIS & RHEUMATOLOGY , pp.626-630.
@article{article, author={Eugene Krustev Et Al. }, title={M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2022, pages={626-630} }